This retrospective claims analysis found that concomitant joint disease in psoriasis is associated with greater health care resource utilization and health care costs than psoriasis alone.
Michelle Skornicki, MPH
Advertisement
Articles by Michelle Skornicki, MPH
Advertisement
Latest Updated Articles
- Economic Burden of Joint Disease in Psoriasis: US Claims Analysis
November 1st 2021
Advertisement
Advertisement
Trending on AJMC
1
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
2
Unanswered Questions in First- and Second-Line mCRC Care
3
Cleveland Clinicians Say Obesity Care Starts Too Late for Many Patients
4
Precision Drugs Meet Payer Realities
5